Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00544388|
Recruitment Status : Completed
First Posted : October 16, 2007
Last Update Posted : December 16, 2013
|Condition or disease||Intervention/treatment||Phase|
|Rhinitis, Allergic, Seasonal||Drug: levocetirizine dihydrochloride||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||570 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Trial to Compare the Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects Exposed to Pollen Challenge in an Environmental Exposure Unit (EEU).|
|Study Start Date :||April 2004|
|Actual Primary Completion Date :||July 2004|
|Actual Study Completion Date :||July 2004|
- Mean change from baseline in major symptom complex score over Period 2 (21-29 hours after drug intake on Day 2).
- Mean change from baseline in MSC score over each 2-hour interval.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00544388
|Study Director:||UCB Clinical Trial Call Center||UCB Pharma|